Author

D. Revinski

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1 Cell Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Organism:human· 2 Assay:proteomics· 2 Research Focus:cell signaling & trafficking· 1 Research Focus:cell type annotation· 1 Research Focus:development & morphogenesis· 1 Research Focus:host-pathogen & immune response· 1 Organism:mouse· 1

Frequent Co-Authors

J.-P. Borg· 2 shared L. Camoin· 2 shared L. Kodjabachian· 2 shared S. Audebert· 2 shared A. Daulat· 1 shared A. Serge· 1 shared A. Walton· 1 shared D. Birnbaum· 1 shared

Activity by Year

2018-2020 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 37 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCell Biology

J.-P. Borg

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

A novel Golgi-associated Vangl2 translational variant required for PCP regulation in vertebrates

A. Walton, D. Revinski, A. Serge, S. Audebert, L. Camoin, T. M. Puvirajesinghe, D. Isnardon, S. Marchetto, L. Kodjabachian, E. Bailly, J.-P. Borg

The paper identifies a novel Vangl2 isoform, Vangl2-Long, which is localized to the Golgi apparatus and plays a critical role in PCP regulation in vertebrates.

bioRxiv · Oct 20, 2020Cell Biology

ECT2 associated to PRICKLE1 are poor-prognosis markers in triple-negative breast cancer

A. Daulat, P. Finetti, D. Revinski, M. S. Wagner, L. Camoin, S. Audebert, D. Birnbaum, L. Kodjabachian, J.-P. Borg, F. Bertucci

The paper identifies PRICKLE1 and ECT2 as poor-prognosis markers in triple-negative breast cancer by showing their interaction and role in RAC1 signaling.

bioRxiv · Dec 14, 2018Cancer Biology